ArticleCureus2026
Acute Fatty Liver of Pregnancy Presenting With Isolated Nausea and Vomiting in the Third Trimester: A Case Report.
Article in Cureus, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Acute fatty liver of pregnancy (AFLP) is a rare but life-threatening obstetric emergency occurring in the third trimester. Its non-specific presentation frequently overlaps with other pregnancy-related conditions, leading to diagnostic delay and increased maternal and fetal morbidity and mortality. We report the case of a 27-year-old primigravida at 38 + six weeks of gestation presenting with isolated nausea and vomiting, without abdominal pain, hypertension, proteinuria, or obstetric complaints. Clinical examination revealed mild jaundice and stable hemodynamics. Initial laboratory investigations demonstrated leukocytosis, hepatic cytolysis, hyperbilirubinemia, coagulation abnormalities, and hypoglycemia. Repeat testing within 10 hours showed rapid biological deterioration with worsening leukocytosis, acute kidney injury, and progressive coagulopathy. In the absence of thrombocytopenia and hypertension, and with fulfillment of eight Swansea criteria, AFLP was strongly suspected. Emergency cesarean section was performed for maternal indication, with prophylactic perioperative coagulation support. A female neonate weighing 2,440 g was admitted briefly to the neonatal intensive care unit for transient respiratory distress. Postpartum maternal recovery was rapid, with normalization of all biological parameters, and both patients were discharged in good condition. AFLP remains a diagnostic challenge due to its non-specific presentation. Early recognition using the Swansea criteria, prompt delivery, and multidisciplinary supportive care are essential to optimize outcomes. Neonatal metabolic screening for fatty acid oxidation disorders should be systematically considered.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.